IGF-DES has a functionality relating to hyperplasia, or the enlargement of an organ or tissue caused by the increase of cell creation. Two of it's main functionalities include initiate cellular repair and quicker wound healing. In most situations, according to researchers, those that use IGF-DES will notice an increase of muscle growth at the injection site. When created by the body, IGF-DES is created by the liver. In the synthetic variation, the last three bonds are removed making it easier for the peptide to bind to lactic acid receptors increasing its overall potency as a peptide.
IGF DES has a functionality relating to hyperplasia, or the enlargement of an organ or tissue caused by the increase of cell creation. The synthetic version of this peptide can initiate cellular repair and quicker wound healing in addition to many other benefits. A nice addition to this peptide working when and where it should be is its ability to increase muscle growth at the injection site and the development of lean muscle mass. IGF DES is typically produced naturally in the liver but can be created in various tissues throughout the body. Its structure is made up of 70 amino acids when created naturally, when created this way its lifespan is relatively short.
However, when created synthetically, the last three bonds are removed to increase the lifespan of the peptide, making it 67 amino acids instead of 70. By creating this synthetic version of the peptide, it allows it to bind to lactic acid receptors which increases its overall potency. When it comes to dosages, it is not recommended to exceed 40 to 50mcg a day for men and no more than 20mcg for women daily.
The effects of taking IGF-DES typically will take a couple of weeks to see. If looking for a full effect it is said to take about three to six months before these results can be seen. The results of taking IGF DES will also depend upon external factors such as age, weight, and health history.
IGF-1 DES is a truncated, natural version (splice variant) of insulin-like growth factor-1. Naturally found in the brain, breast milk, and uterine tissue, IGF-1 DES stimulates hypertrophy and hyperplasia of a number of different cell lines. Research has shown this version of the protein to be more potent than standard IGF-1, mostly as a result of its enhanced bioavailability. Currently, researchers are looking at ways to utilize IGF-1 DES in the treatment of inflammatory bowel disease (IBD), autism, and a variety of neurological conditions. Research shows that it helps to maintain the health of synaptic connections in the central nervous system and, like all IGF-1, promotes the repair of muscle and connective tissue.






